May 20, 2012

FDA Approved Monoclonal Antibodies (mAbs) for Cancer Therapy

Graph of FDA Approved Monoclonal Antibodies (mAbs) for Cancer Therapy

The following image may be reproduced without modification using the attribution “Graph source – MD Becker Partners (www.mdbpartners.com).”  Click on the image to enlarge.

Cancer Vaccine Therapies: Failures and Future Opportunities

FIGURE 1: FDA APPROVAL OF CANCER MABS FROM 1997-2010

(Note: the following text is an Executive Summary from our new 150-page report titled “Cancer Vaccine Therapies: Failures and Future Opportunities”) Since the early 1990s, cancer immunotherapy has provided hope to patients, physicians, and investors as a new treatment modality with limited side effects and superior efficacy.  Cancer immunotherapy broadly includes passive immunization, active immunization, [...]

Much Ado About Medarex

475803-small

According to their website, Discovery’s Edge is the Mayo Clinic’s online research magazine that is designed to communicate the story of scientists and researchers who are bringing treatments and improved care to patients and also reports on “works–in–progress.”  Through this publication, Mayo investigators studying immunotherapy for aggressive prostate cancer reported over the past weekend that [...]